HAVCR2 and glioma: Studies have confirmed that the increased immune checkpoints such as PD-L1, CTLA-4, TIM-3, and LAG3 in glioma help tumor immune evasion, leading to T-cell dysfunction (Xue et al., 2017; Woroniecka et al., 2018).